Loading…
uniQure N.V. is projected to rise to $31.56 by 2027, a +25% move from its current price of $25.17. QURE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $23.98 | $25.18 | $26.44 | +0.04% |
| May 30 | $23.51 | $25.19 | $27.00 | +0.08% |
| May 31 | $23.15 | $25.20 | $27.43 | +0.13% |
| Jun 1 | $22.86 | $25.21 | $27.80 | +0.17% |
| Jun 2 | $22.61 | $25.22 | $28.14 | +0.21% |
| Jun 3 | $22.38 | $25.23 | $28.45 | +0.25% |
| Jun 4 | $22.18 | $25.24 | $28.73 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.18 | $25.24 | $28.73 | +0.29% |
| Week 2 | $21.08 | $25.32 | $30.40 | +0.59% |
| Week 3 | $20.29 | $25.39 | $31.77 | +0.88% |
| Week 4 | $19.66 | $25.47 | $32.99 | +1.18% |
| Week 5 | $19.12 | $25.54 | $34.12 | +1.47% |
| Week 6 | $18.66 | $25.62 | $35.17 | +1.77% |
| Week 7 | $18.24 | $25.69 | $36.18 | +2.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
uniQure N.V. is a healthcare company focused on developing treatments for patients suffering from rare and other devastating diseases in the United States. It operates in the Healthcare category and aims to bring therapies to market for serious conditions.
It offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease.
It also develops AMT-260, which is in Phase I/IIa clinical trial to treat mesial temporal lobe epilepsy; AMT-162 is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191 is an investigational gene therapy candidate which is in Phase I/IIa clinical trial for the treatment of fabry disease. UniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
UniQure N.V. (QURE) is a healthcare stock trading at $24.19 per share with a market capitalization of $1.53B.
Its market position is reflected by a rank of 2214.
Forecasts indicate a bullish path over the coming years, with the 2026 average price at $24.19 and rising to $30.13 in 2027, $56.82 in 2030, $152.77 in 2040, and $381.07 in 2050.
The forecast also shows returns on investment (ROI) of 0% in 2026, 24.6% in 2027, 38% in 2028, 45.7% in 2029, 134.9% in 2030, 186% in 2031, 191% in 2032, 259.1% in 2033, 242.4% in 2034, 231.9% in 2035, 531.5% in 2040, and 1475.3% in 2050, with a bullish sentiment across these years.
A major floor 64.1% below — a decisive break under it would weaken the trend.
The nearest floor, 33.5% below — buyers have tended to step in here.
The nearest ceiling, 15.9% above — a clean break opens room to run.
A major ceiling 43.5% above — clearing it would confirm fresh momentum.
Key QURE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QURE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.77 | Buy | $25.04 | Buy |
| MA 10 | $25.75 | Sell | $25.06 | Buy |
| MA 20 | $24.32 | Buy | $24.00 | Buy |
| MA 50 | $19.69 | Buy | $21.73 | Buy |
| MA 100 | $20.49 | Buy | $21.87 | Buy |
| MA 200 | $26.39 | Sell | $22.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.07 | Neutral |
| Stoch RSI (14) | 14.44 | Buy |
| CCI (20) | 21.88 | Neutral |
| Williams %R (14) | -79.68 | Info |
| MACD (12,26,9) | -0.36 | Sell |
| ROC (12) | -9.00 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 20.32 | Neutral |
| TRIX (15) | 1.51 | Buy |
| Awesome (5,34) | 3.32 | Buy |
| Ultimate (7,14,28) | 42.14 | Neutral |
| Momentum (10) | -3.93 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 24.50 | Buy |
| ADX (14) | 23.16 | Buy |
| ATR (14) | 0.84 | Info |
The 30-day technical picture is bullish. The sentiment is bullish, with RSI14 at 60.
Key moving averages show near-term momentum, with SMA50 at $19.32 and SMA200 at $26.28. This framework helps define near-term support at $16.73 and resistance at $29.17.
In the last 30 days the price traded within a $17.23 to $33.95 range. Annualized volatility stands at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.03 | $25.17 | $37.19 | 0% | Neutral | |
| $23.11 | $31.56 | $46.55 | +25% | Bullish | |
| $24.69 | $35.57 | $55.55 | +41% | Bullish | |
| $24.86 | $37.50 | $61.23 | +49% | Bullish | |
| $37.94 | $59.64 | $101.06 | +137% | Bullish | |
| $45.02 | $73.58 | $128.75 | +192% | Bullish | |
| $44.12 | $74.81 | $134.69 | +197% | Bullish | |
| $52.05 | $91.42 | $168.88 | +263% | Bullish | |
| $49.34 | $89.69 | $169.61 | +256% | Bullish | |
| $46.56 | $87.51 | $169.10 | +248% | Bullish | |
| $75.74 | $167.11 | $353.06 | +564% | Bullish | |
| $184.90 | $410.89 | $945.04 | +15.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $9.03 | $25.17 | $29.77 | +0.00% |
| June 2026 | $21.55 | $25.75 | $31.82 | +2.30% |
| July 2026 | $21.55 | $26.15 | $33.08 | +1.55% |
| August 2026 | $20.56 | $25.26 | $32.52 | -3.41% |
| September 2026 | $20.82 | $25.83 | $33.74 | +2.28% |
| October 2026 | $22.22 | $27.83 | $36.83 | +7.73% |
| November 2026 | $22.25 | $28.09 | $37.60 | +0.95% |
| December 2026 | $21.61 | $27.50 | $37.19 | -2.13% |
Click any year to see its month-by-month QURE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The QURE price prediction for 2026 points to an average of $25.17 (low $9.03, high $37.19) — a potential gain of 0% on today's $25.17. Price action looks broadly range-bound.
In 2027, QURE is projected to trade between $23.11 and $46.55, averaging $31.56 — a potential gain of +25% from today's $25.17. That is up +25% on the projected 2026 average. Buyers look set to stay in control over this stretch.
uniQure N.V.'s 2028 outlook centres on $35.57, within a $24.69 to $55.55 range. That is up +13% on the projected 2027 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2029, QURE could reach as high as $61.23, with a base case around $37.50 and support toward $24.86 — roughly +49% from $25.17. Buyers look set to stay in control over this stretch.
Expect QURE to range from $37.94 to $101.06 through 2030. The $59.64 average target implies a +137% move from current prices. That is up +59% on the projected 2029 average. Momentum favours further upside here.
The QURE price prediction for 2031 points to an average of $73.58 (low $45.02, high $128.75) — a potential gain of +192% on today's $25.17. Buyers look set to stay in control over this stretch.
In 2032, QURE is projected to trade between $44.12 and $134.69, averaging $74.81 — a potential gain of +197% from today's $25.17. That is up +2% on the projected 2031 average. Momentum favours further upside here.
uniQure N.V.'s 2033 outlook centres on $91.42, within a $52.05 to $168.88 range. That is up +22% on the projected 2032 average. That marks a +263% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, QURE could reach as high as $169.61, with a base case around $89.69 and support toward $49.34 — roughly +256% from $25.17. Momentum favours further upside here.
Expect QURE to range from $46.56 to $169.10 through 2035. The $87.51 average target implies a +248% move from current prices. That is -2% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The QURE price prediction for 2040 points to an average of $167.11 (low $75.74, high $353.06) — a potential gain of +564% on today's $25.17. Momentum favours further upside here.
In 2050, QURE is projected to trade between $184.90 and $945.04, averaging $410.89 — a potential gain of +15.3x from today's $25.17. That is up +146% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in QURE today (≈ 39.729837 QURE) could be worth
$16,324.43
+$15,324.43 (+1532%) by 2050 · US Dollar
Based on the average projected QURE price of $410.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QUREwould be worth at today's price.
$1,000 invested in QURE on May 27, 2025 (≈ 64.516129 QURE) would be worth
$1,623.87
+$623.87 (+62.4%) today · 1.62× · US Dollar
Based on a QURE entry price of $15.5 vs. today's $25.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.6 | $1,023.17 | +2.3% |
| 1 month ago | $17.9 | $1,406.15 | +40.6% |
| 3 months ago | $17.11 | $1,470.64 | +47.1% |
| 6 months ago | $27.51 | $914.94 | -8.5% |
| 1 year ago | $15.5 | $1,623.87 | +62.4% |
| All time (5.0y) ago | $34.56 | $728.3 | -27.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QURE forecast.
Our base-case forecast reaches $50.00 around 2030.
Implied market cap at $50.00: $3.15B
The multi-year forecast paints a bullish path with notable upside. By 2030 the average price is expected to be $56.82 with a ROI of 134.9%.
By 2040 the average price rises to $152.77 with a ROI of 531.5%, and by 2050 the average price reaches $381.07 with a ROI of 1475.3%.
These estimates carry uncertainty and the upside rests on bullish sentiment persisting across the forecast. The projected path reflects strong gains in later years while recognizing the high variability implied by the data (annualized volatility of 100%).
Tap a question to reveal the answer.
The forecast shows a 2030 average price of $56.82 with a min of $35.44, a max of $97.89, a ROI of 134.9%, and bullish sentiment.
Forecasts indicate bullish sentiment from 2027 onward, with rising averages (e.g., 2027 avg $30.13, 2028 avg $33.38, 2029 avg $35.23, 2030 avg $56.82). These figures are estimates and do not guarantee results.
According to the forecast, the 2030 max is $97.89 and the 2031 max is $123.21, so reaching $100 is possible by 2031.
Current price is $24.19 and market cap is $1.53B.
The 30-day range is $17.23 to $33.95, and annualized volatility is 100%, indicating high variability.
uniQure N.V. Community Discussion
0Share your uniQure N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.